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Background and purpose: To assess the relationship between plaque volume evaluated 
by multidetector computed tomographic angiography (MDCT) and in-stent restenosis 
(ISR) after carotid artery stenting (CAS). 
Materials and Methods: From a retrospectively maintained database, data were 
collected for 52 patients with carotid artery stenosis treated with CAS between 2007 and 
2012. We defined ISR of ≥50% as a peak systolic velocity ≥ 200 cm/s on echo-duplex 
scan. Carotid plaques were subdivided into 4 components according to radiodensity in 
Hounsfield units (HU) as follows: <0, 0–60, 60–130, and >600 HU. Risk factors that 
influenced ISR were compared using univariate and multivariate Cox regression 
analyses. 
Results: During a median follow-up period of 36 months, ISR of ≥50% was detected in 
5 patients (9.6%). In the univariate Cox proportional hazard regression analysis, renal 
insufficiency, coronary artery disease, total plaque volume, and plaque volumes with 
radiodensities <0 and ≥600 HU increased the risk for ISR (P < .10). When the 
significant risk factors determined from the univariate analysis were subjected to a 
multivariate analysis, only the volumes of the plaque components with radiodensities <0 
HU independently predicted the development of ISR (hazard ratio, 1.041; 95% 
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confidence interval, 1.006–1.078; P = .021). 
Conclusion: Our data suggest that the high volume of the plaque components with 
radiodensities <0 HU was independently associated with the increased risk of ISR after 
CAS. Quantitative and qualitative tissue characterizations of carotid plaques using 
MDCT might be a useful predictive tool of the development of ISR.  
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Intruduction 
Carotid artery stenting (CAS) has been developed as a potential therapeutic 
alternative to carotid endarterectomy (CEA) for the treatment of atherosclerotic lesions 
of the carotid artery. The number of patients who developed in-stent restenosis (ISR) 
has increased with the increase in the number of CAS patients who have undergone 
long-term monitoring.  The neointimal formation occurs in the surface of the stent 
within almost one year after CAS, and the ISR is reportedly caused by the further 
progression of arteriosclerosis within the stent after neointimal formation.(1),(2),(3) 
Persistence of inflammatory stimuli and subsequent cellular proliferation within 
vulnerable plaque is considered to play an important role in occurrence of the ISR after 
CAS, and preoperative evaluation of vulnerable plaque may be useful for the prediction 
of the development of ISR due to in-stent arteriosclerosis.  We previously reported the 
utility of multidetector computed tomography (MDCT) in diagnosis of vulnerable 
7 
 
plaque, in this article the plaque components with radiodensities <0 Hounsfield units 
(HU) on MDCT, which are consistent with lipid core, are associated with the number of 
distal embolisms after CAS.(4)  These lipid components may also be associated with 
ISR because vulnerable plaque is considered to cause the intense arteriosclerosis in the 
stent. (2),(3)  In this study, we describe the usefulness of MDCT plaque diagnosis as a 
preoperative predictor of restenosis after CAS.  
 
Materials and methods 
Patient selection and data collection. Between January 2007 and August 2012, 
we performed 52 CAS procedures to treat 52 consecutive patients using preoperative 
MDCT imaging at Kanazawa University Hospital. Patients were included if MDCT for 
the target carotid artery was performed preoperatively and follow-up echo-duplex scans 
were obtained 24 h, 3 months, 6 months, and 12 months after CAS and every year 
thereafter. Three patients for whom a MDCT study could not be performed because of 
severe renal failure were excluded. Of 52 lesions, 36 (69.2%) were symptomatic and 16 
(30.8%) were asymptomatic. The following patient baseline characteristics were 
recorded: age, sex, degree of stenosis, hypertension, diabetes mellitus (medication 
dependent, including oral hypoglycemic agents and insulin), dyslipidemia (medication 
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dependent or with a serum cholesterol level ≥ 220 mg/dL or serum triglyceride level ≥ 
150 mg/dL), renal insufficiency (estimated glomerular filtration rate < 30 mL/min/1.73 
m2), coronary artery disease (history of angina pectoris or myocardial infarction), 
peripheral vascular disease, contralateral carotid occlusion, prior neck radiotherapy, 
smoking habit (still smoking or stopped smoking < 6 months before the study), stent 
type, postdilation, and antiplatelet medication after CAS. Intraoperative and 
postoperative events were also recorded. Our institutional review board did not require 
informed consent for participation in this study because our analysis relied on the 
information obtained as part of the routine clinical care of patients.   
Indications for CAS were ICA stenosis > 50% in symptomatic patients and 
80% in asymptomatic patients, with one of the following comorbidities: 2 or more 
coronary vessels with >70% stenosis, bronchopulmonary obstructive disease, 
post-carotid endarterectomy restenosis, previous radical neck surgery or radiotherapy, 
surgically inaccessible lesions, and contralateral carotid artery occlusion. ICA stenosis 
was diagnosed using angiography. 
MDCT examination. Scanning was performed on a 64-slice MDCT scanner 
(GE Medical Systems, Milwaukee, WI) with a standardized protocol (120 kVp; 350 
mAs; collimation, 64 × 0.625 mm; table feed, 10.62 mm/rotation; pitch, 0.531). All the 
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patients received 80 mL of contrast material (370 mg/mL) at an injection rate of 4 mL/s. 
Saline was not injected after the administration of the contrast material. Synchronization 
between the passage of contrast material and data acquisition was achieved with a bolus 
tracking technique. The scan was triggered automatically by means of the threshold, 
measured in a region of interest (ROI) set in the internal carotid artery. The threshold 
was set at 100 HU. Image reconstructions were rendered with an intermediate 
reconstruction algorithm with the following characteristics: field of view, 160 mm; 
matrix size, 512 × 512; slice thickness, 0.625 mm; and interval, 0.3 mm. Data were 
transferred to our workstation (GE Advantage Windows version 4.4, GE Medical 
Systems). Plaque component areas were automatically measured using the Advanced 
Vessel Analysis software (GE Medical Systems). After manual drawing of the ROI 
encircling the internal carotid artery, the number of pixels of the different HU values 
within the ROI was automatically calculated. The lumen area, which is filled with 
contrast media that has radiodensity of 130-600, was automatically differentiated from 
the atherosclerotic plaque based on the adjusted cutoff value. The carotid plaque was 
expediently subdivided into 4 components according to radiodensity as follows: <0, 0–
60, 60–130, and >600 HU, as assessed in previous studies (Fig. 1).(4,5) The volumes of 
the atherosclerotic plaque and its component were calculated by multiplying the 
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calculated number of pixels, pixel size, and increment. Two observers (K.M. and N.U.), 
who were blinded to other clinical information, performed the volume measurements. 
CAS procedure. Dual (aspirin 100 mg and clopidogrel 75 mg) or triple 
antiplatelets (aspirin 100 mg, clopidogrel 75 mg, and cilostazol 200 mg) were 
administered for a minimum of 7 days prior to the procedure. The patients were placed 
under local anesthesia, and a bolus injection of heparin (70 IU/kg) was given 
immediately before the intervention to increase the activated clotting time to a minimum 
of 300 s. A 6-F, 90-cm catheter sheath was inserted from the femoral artery to the 
ipsilateral common carotid artery proximal to the stenosis. We used Angioguard 
(Johnson & Johnson, Cordis, Minneapolis, MN) or FilterWire (Boston Scientific, Natick, 
MA, USA) as the embolic protection device for all the patients. All but 4 patients 
underwent predilation of the internal carotid lesions. The predilation was performed 
using a 3.5-mm balloon catheter protected with the embolic protection device. A 
self-expandable stent, either Precise (Johnson & Johnson, Cordis) or Wallstent RP 
(Boston Scientific), was used in all the patients. Postdilation was performed with a 4.5- 
or 5-mm balloon catheter; the inflation pressure was 8 atm. In cases with insufficient 
stent expansion, the balloon was additionally inflated up to 10 atm. 
Follow-up. The patients underwent an echo-duplex scan, and neurological 
11 
 
examinations of all the patients were performed at 24 h, 3 months, 6 months, and 12 
months after CAS and yearly thereafter. ISR was defined as an arterial narrowing of 
50% or more, which was reported to be equivalent to a peak systolic velocity (PSV) ≥ 
200 cm/s.(6),(7) 
Statistical analysis. Time to restenosis was analyzed using survival analysis 
methods. Survival curves were estimated using the Kaplan-Meier method. Univariate 
and multivariate Cox proportional hazard regression models were used to determine risk 
factors of the development of restenosis. The risk factors investigated included sex, 
degree of stenosis, symptomatic lesion, hypertension, diabetes mellitus, dyslipidemia, 
renal insufficiency, coronary artery disease, peripheral vascular disease, contralateral 
carotid occlusion, prior neck radiation, smoking, stent type, postdilation, postprocedural 
medications (aspirin, clopidogrel, and cilostazol), PSV assessed by echo-duplex scan, 
and plaque volume. For each risk factor, hazard ratio and the associated 95% confidence 
interval (CI) from the univariate analysis were calculated. Multivariate analysis was 
conducted for the risk factors with significant P values (<.10) in the univariate analysis. 
All the analyses were conducted using the SPSS version 19 statistical software (SPSS 





The baseline characteristics of the patients are shown in Table 1. Of the 52 
patients, 44 (84.6%) were men and 8 (15.4%) were women. Their mean age was 69.8 ± 
7.7 years (range, 52–84 years). The clinical data included symptomatic stenosis in 36 
(69.2%) patients, hypertension in 38 (73.1%), diabetes mellitus in 24 (46.2%), 
dyslipidemia in 22 (42.3%), renal insufficiency in 5 (9.6%), coronary artery disease in 
14 (26.9%), peripheral vascular disease in 5 (9.6%), contralateral carotid occlusion in 3 
(5.8%), prior neck radiation in 2 (3.8%), and smoking in 36 (69.2%). 
All the CAS procedures performed were successful, and excellent lesion 
dilation was achieved. The deployed stent was Precise (Johnson & Johnson, Cordis) in 
38 (73.1%) and Wallstent RP (Boston Scientific) in 14 patients (26.9%). None of the 
patients needed more than 1 stent. Postdilation was performed in 41 patients (78.8%) 
using a 4.5- or 5-mm balloon catheter. The overall periprocedural complication rate was 
3.8% (2 cases, 1 minor stroke and 1 hyperperfusion syndrome). No fatal complications 
or major stroke events were encountered. 
During the median follow-up period of 36 months (interquartile range, 24.0–
42.0), an ISR ≥ 50% was detected in 5 patients (9.6%). None of the patients with ISR 
had a neurological event ipsilateral to the restenosed vessel and needed retreatment. 
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Plaque volume could be calculated for all the 52 patients (Table 1). The total 
plaque volumes (mean ± standard deviation) in all the patients, in those with restenosis, 
and in those without restenosis were 671 ± 426, 1101 ± 310, and 625 ± 413 mm3, 
respectively. The volumes of the plaque components with radiodensities < 0, 0–60, 60–
130, and >600 HU were respectively 11 ± 26, 280 ± 206, 340 ± 247, and 40 ± 70 mm3 
for all the patients; 30 ± 29, 415 ± 239, 530 ± 221, and 126 ± 99 mm3 for those with 
restenosis; 9 ± 25, 265 ± 200, 320 ± 243, and 31 ± 61 mm3 for those without restenosis 
(Table 1). 
In the univariate analysis, renal insufficiency, coronary artery disease, total 
plaque volume, and plaque volume with a radiodensity <0 or ≥600 HU were associated 
with the development of ISR (P < .10; Table 2). The unadjusted and adjusted hazard 
ratios for the ISR among the patients with plaque components with radiodensities <0 
HU were 1.020 (95% CI, 1.001–1.040; P = .036) and 1.041 (95% CI, 1.006–1.078; P 
= .021), respectively. The receiver-operating characteristic curve of the volumes of the 
plaque components with radiodensities <0 HU showed a cutoff plaque volume of 7.85 
mm3 for the prediction of carotid artery ISR, with a sensitivity of 80% and specificity of 
83%. The area under the curve was 0.85 (Fig. 2). Figure 3 shows the Kaplan-Meier 
estimated curves for the patients who had plaque volumes > 7.85 mm3 for components 
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with radiodensities <0 HU and for those patients whose plaque volumes did not fall 




This is the first study to investigate the risk of ISR through plaque diagnosis on 
MDCT. Previously reported risk factors for restenosis include diabetes mellitus,(8) 
residual stenosis after CAS,(9-11) multiple stent implantation,(10,11) smoking,(8) 
calcified plaque,(8) previous CEA,(8,12),(13) history of neck cancer,(14) and neck 
radiotherapy.(13) However, no previous study on risk factors of restenosis has been 
conducted using quantitative and qualitative plaque analyses. In the present study, the 
multivariate analysis showed that the total volume of the plaque components with 
radiodensities <0 HU (lipid core) was significantly correlated with restenosis. 
One study that compared between histological diagnosis based on plaque 
excised during CEA and histological diagnosis based on pretreatment MDCT reported 
that plaques with radiodensities <60 HU were lipid-rich. We previously reported that 
even among plaques with radiodensities <60 HU, those with radiodensities <0 HU were 
strongly correlated with the number of peripheral embolisms after CAS, indicating the 
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presence of unstable plaques.(4) Plaque components in the coronary artery region that 
have radiodensities <0 HU are referred to as the “lipid pool”(15,16) and are associated 
with no-flow conditions after percutaneous coronary intervention. Therefore, they can 
be regarded as components indicative of the presence of unstable plaques.(17) Plaque 
components with radiodensities <0 HU only comprise part of the total plaque volume in 
both the coronary and carotid arteries.(4,15) In this study, we found that they accounted 
for less than one-tenth of the total amount of plaque. In the event of intraplaque 
hemorrhage, the effect of the ensuing hematoma may mean that even if a lipid pool is 
present, its radiodensity may not be <0 HU. The reason as to why the nature of plaque is 
indicated by this minor component requires further investigation. 
During the first 12 months after CAS, neointimal proliferation, which consists 
of transformed smooth muscle cells and fibrotic maturation of the matrix substances, is 
observed inside the stent struts. ISR after CAS is believed to occur owing to the 
subsequent further progression of arteriosclerosis in the neointima.(1)-(3),(18) The 
association we found in this study between components with radiodensities <0 HU, 
which indicate the presence of unstable plaques, and restenosis strongly suggests the 
progression of arteriosclerosis inside the stent. In 4 of the 5 patients in whom restenosis 
occurred, stenosis progressed after at least a year had passed since CAS, a course 
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consistent with changes following neointimal formation. 
Although one investigation found that restenosis commonly consists of 
concentric calcified plaques, it did not evaluate the amount or severity of 
calcification.(8) MDCT provides outstanding spatial resolution and is particularly useful 
for quantifying the extent of calcified lesions.(4),(5,19)(20)(21) In the present study, the 
univariate analysis showed that a large volume of calcified plaque with a radiodensity 
≥600 HU was associated with restenosis. In terms of the mechanism whereby calcified 
plaque causes restenosis, some authors have reported that calcification may prevent the 
full dilatation of stents.(9),(11) In this study, the peak velocity measured by carotid 
artery ultrasonography on the day after the treatment made no difference in restenosis, 
suggesting that inadequate dilation could not have been the cause (Table 1). 
Other factors that are reportedly correlated with restenosis include previous 
CEA,(8,12),(13) history of neck cancer,(14) and neck radiotherapy.(13) However, in our 
study we did not find any significant difference for any of these factors, probably owing 
to the small number of patients. Therefore, further studies of more cases are required. 
Limitations of the study. The number of patients and clinical events were 
small, and the study was retrospective in nature. Although the result of our MDCT 
analysis was consistent with those of other published studies,(4) the patterns observed 
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on MDCT require verification by histopathological examination of carotid plaque. In 
particular, the corresponding histological characteristics of the specific components with 
radiodensities <0 HU remain to be determined. We did not perform any examination for 
intraplaque hemorrhage or thrombus. MDCT can differentiate between calcification, 
fibrous tissue, and lipid cores. However, because hemorrhage could not be distinguished 
reliably from lipid cores in this study, they were not reported separately. 
 
Conclusions 
Our data suggest that the high total volume of the components with 
radiodensities <0 HU was independently associated with the increased risk of ISR after 
CAS. MDCT may be useful in the pretreatment quantitative and qualitative assessments 
of carotid plaque for the prediction of ISR after CAS. 
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Fig 1. Representative images of multidetector computed tomography (MDCT) and 
echo-duplex scan of a patient who had in-stent restenosis at 12 months 
follow-up.   
A,B:  Sagittal sectional (A) and color mapped (B) images of the plaque on MDCT. The 
red, yellow, green and blue areas indicate that the Hounsfield value is <0, 0–60, 
60–130, and >600, respectively.  The grey area indicates intraluminal contrast 
media that has radiodensity of 130-600.   The plaque volume in the red, yellow 
and blue area accounts for 22.2, 259.9, 568.7 and 268.2 mm3, respectively.  
C,D,E,F: Color Doppler sonography one day after carotid artery stenting (CAS) (C) 
shows favorable dilatation of carotid artery with the peak systolic velocity of 96 
cm/s (E), whereas in-stent restenosis is depicted 12 months after CAS (D) with 
the peak systolic velocity of 229cm/s (F). Arrow indicates the in-stent restenosis.   
 
Fig 2. Receiver-operating characteristic curve of the volumes of the plaque components 
with radiodensities < 0 Hounsfield units for the prediction of carotid artery 
in-stent restenosis. A plaque volume of 7.85 mm3 provides a sensitivity of 80% 




Fig 3. Kaplan-Meier analysis result comparing the cumulative freedom from in-stent 
restenosis between the patients with plaque volumes > 7.85 mm3 for components 
with radiodensities <0 HU (solid line) and those whose plaque volumes did not 
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Male 44 (85) 5 (100) 39 (83) 0.208
Degree of stenosis (%) 0.116
Past history
  Symptomatic stenosis 36 (69) 4 (80) 32 (68) 0.843
  Hypertension 38 (73) 4 (80) 34 (72) 0.645
  Diabetes mellitus 24 (46) 1 (20) 23 (49) 0.165
  Dyslipidemia 22 (42) 2 (40) 20 (43) 0.806
  Renal insufficiency 5 (10) 3 (60) 2 (4) 0.002
  Coronary artery disease 14 (27) 3 (60) 11 (23) 0.057
  Peripheral vascular disease 5 (10) 0 (0) 5 (11) 0.686
  Contralateral carotid occlusion 3 (6) 0 (0) 3 (6) 0.694
  Prior neck radiation 2 (4) 0 (0) 2 (4) 0.767
  Smoking 36 (69) 4 (80) 32 (68) 0.696
Stent
  Wallstent 14 (27) 1 (20) 13 (28) 0.996
  Precise 38 (73) 4 (80) 34 (72) 0.996
Post-dilatation 41 (79) 5 (100) 36 (77) 0.416
Post-procedure medications
  Aspirin 34 (65) 5 (100) 29 (62) 0.357
  Clopidogrel 23 (44) 1 (20) 22 (47) 0.368
  Cilostazol 17 (33) 1 (20) 16 (34) 0.547
Peak systolic velocity (cm/s)
  Preoperative 0.933
  One day after treatment 0.982
  Last examination 0.001
Plaque volume (mm3)
  Total 0.043
    HU＜0 0.036
    HU 0-60 0.177
    HU 60-130 0.141
    HU ≧600 0.020
HU, Hounsfield unit. 























Table 1. Baseline characteristics
625±413





No restenosis (n  = 47)
671±426
Unadjusted hazard ratio Adjusted hazard ratio
(Confidence intervals) P- value (Confidence intervals) P- value
Renal insufficiency 17.734 (2.949-106.641) 0.002 －
Coronary artery disease 6.241 (0.948-41.104) 0.057 －
Plaque volume: Total 1.001 (1.000-1.003) 0.043 －
Plaque volume: HU<0 1.020 (1.001-1.040) 0.036 1.041 (1.006-1.078) 0.021
Plaque volume: HU≧600 1.008 (1.001-1.015) 0.020 －
HU, Hounsfield unit. 











































62.5% (SE 15.1%) 
40          40  40  40  39  39 39  
12          10   8   8   8      
Volume≦7.85 
Volume＞7.85  
Fig 3. 
Volume≦7.85  
Volume＞7.85  
